Valuation Artivion, Inc. Deutsche Boerse AG
Stocks
CYL
US2289031005
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.30 EUR | -1.08% |
|
+3.39% | -53.14% |
| 06-15 | Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing | MT |
| 05-18 | Artivion Closes $175 Million Acquisition of Endospan | MT |
Company Valuation: Artivion, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 800.4 | 488.8 | 733.9 | 1,198 | 2,161 | 1,029 | - | - |
| Change | - | -38.93% | 50.16% | 63.29% | 80.29% | -52.4% | - | - |
| Enterprise Value (EV) | 1,058 | 761.4 | 733.9 | 1,198 | 2,161 | 1,029 | 1,029 | 1,029 |
| Change | - | -28.05% | -3.6% | 63.29% | 80.29% | -52.4% | 0% | 0% |
| P/E | -53.6x | -25.3x | -23.8x | -89.3x | 217x | 171x | 49.6x | 25.3x |
| PBR | 2.7x | 1.72x | - | - | - | - | - | - |
| PEG | - | -1x | -0.4x | 1.6x | -1x | -4.2x | 0x | 0.3x |
| Capitalization / Revenue | 2.68x | 1.56x | 2.07x | 3.08x | 4.9x | 2.11x | 1.9x | 1.71x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.11x | 1.9x | 1.71x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.7x | 8.84x | 7.28x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 30.5x | 17.6x | 12.8x |
| EV / FCF | - | - | - | - | - | -53x | 53x | - |
| FCF Yield | - | - | - | - | - | -1.89% | 1.89% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.38 | -0.48 | -0.75 | -0.32 | 0.21 | 0.1238 | 0.4275 | 0.8375 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 298.8 | 313.8 | 354 | 388.5 | 441.3 | 486.4 | 540 | 601.2 |
| EBITDA 1 | 44.28 | 41.56 | 53.82 | 71.26 | 89.6 | 96.55 | 116.4 | 141.3 |
| EBIT 1 | 8.117 | 6.201 | 5.742 | 38.87 | 33.74 | 33.73 | 58.32 | 80.4 |
| Net income 1 | -14.83 | -19.19 | -30.69 | -13.36 | 9.768 | 5.106 | 22.61 | 39.31 |
| Net Debt | 257.8 | 272.6 | - | - | - | - | - | - |
| Reference price 2 | 20.35 | 12.12 | 17.88 | 28.59 | 45.61 | 21.19 | 21.19 | 21.19 |
| Nbr of stocks (in thousands) | 39,330 | 40,329 | 41,049 | 41,920 | 47,375 | 48,543 | - | - |
| Announcement Date | 2/17/22 A | 2/16/23 A | 2/15/24 A | 2/24/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.24x | 3.3x | 12.38x | 2.88% | 154B | |
| 19.94x | 3.45x | 12.41x | 3.6% | 102B | |
| 34.44x | 8.39x | 21.94x | 1.17% | 56.51B | |
| 14.32x | 0.17x | 10.77x | 0.87% | 52.89B | |
| 35.88x | 2.9x | 9.94x | 2.67% | 39.67B | |
| 34.4x | 1.28x | 11.29x | 0.23% | 30.39B | |
| 29.61x | 5.28x | 16.83x | -.--% | 27.96B | |
| 38.95x | 6.73x | 24.3x | 0.27% | 23.17B | |
| 23.99x | 3.06x | 12.49x | 1.35% | 20.35B | |
| Average | 28.20x | 3.84x | 14.70x | 1.45% | 56.31B | |
| Weighted average by Cap. | 25.35x | 3.67x | 13.82x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AORT Stock
- CYL Stock
- Valuation Artivion, Inc.
Select your edition
All financial news and data tailored to specific country editions
